Sumitomo Dainippon Feeling Sense of Crisis about Operating Profit to Approach Zero; Will Offer Early Retirement and Cut Executive Compensation

Sumitomo Dainippon Pharma recently announced an early retirement program because of a delay in new drug launches, sluggish sales of existing products, and a continuing decline in sales in the Japanese market due to inroads by generic drugs. Its operating...read more